New data shows that regular screening with mammography reduces the rate of advanced and fatal breast cancers significantly.
The purpose of cancer screening is to identify tumors early when they are treatable. It helps to prevent the rise of advanced cancer cases associated with poor prognosis.
The data on mammography has been conflicting since some evidence suggests that screening can detect small, slow-growing tumors but will not prevent cancers diagnosed late.
In new study findings;
There was a 41% reduced risk of patients dying from breast cancer in 10 years and a 25% decreased incidence of advanced breast cancer after undergoing screening. This means that effective treatment is possible with early detection.
It confirms the findings of an earlier study that had evidence to prove that screening can reduce risks and incidences of fatal breast cancers. However, mammography screening only works by diagnosing breast cancer early to ensure treatment is successful, and recurrence with distant metastases and death does not occur.
Breast cancer can be less fatal when diagnosed at an early stage. In the study, the risk reduction benefit is attributed to mammography screening. The study findings support the laid guidelines for screening, and women can lower their risk of dying from breast cancer by adhering to the guidelines. The annual screening guidelines for women at average risk recommend that they should start screening at age 40.
This study now confirms that breast cancer mortality has improved because of treatment breakthroughs as well as early mammography screening. It also goes to show that treatment alone is not enough; screening can also help save more lives.
The mortality benefits for breast cancer are due to participation in routine mammography screening, independent of the new advances in treatment. This can help to reduce advanced and fatal stage breast cancers as well as a patient’s risk of dying from the disease. Overall, the large-scale study shows that mammography screening can bring long-term outcomes for breast cancer patients.